Govt should mandate PG cos to supply small quantities 'as required' by MSMEs to halt contamination: TN IDMA: Peethaambaran Kunnathoor, Chennai Wednesday, October 22, 2025, 08:00 H ...

Health ministry to mandate tracking mechanism for vaccines, antimicrobials, cancer and N&P drugs: Gireesh Babu, New Delhi Wednesday, October 22, 2025, 08:00 Hrs [IST] The Union mi ...

Govt discusses challenges faced by exporters during import, export clearance of temperature sensitive consignments: Shardul Nautiyal, Mumbai Wednesday, October 22, 2025, 08:00 Hrs ...

Centre to amend Drugs Rules related to licensing of stem cell derived & gene therapy products: Gireesh Babu, New Delhi Wednesday, October 22, 2025, 08:00 Hrs [IST] The Union minis ...

Health ministry issues draft amendment to move preparations with higher alcoholic content under Schedule H1: Gireesh Babu, New Delhi Wednesday, October 22, 2025, 08:00 Hrs [IST] T ...

MITM IPA-Mysuru Local Branch, JSS Pharmacy College, Mysuru & others note importance of Healthy Women –Healthy Society: Our ...

Thermo Fisher expands global footprint in North America & Europe for sterile drug product development and commercial manufacturing: Waltham, Massachusetts Friday, December 11, 202 ...

Tolremo therapeutics completes first in human dose escalation for TT125-802 and presents solid tumour monotherapy results at ESMO 2025: Basel Monday, October 20, 2025, 15:30 Hrs [ ...

Renalys Pharma reaches Japan PMDA agreement on phase III trials of sparsentan for FSGS and Alport syndrome: Tokyo, Japan Monday, October 20, 2025, 18:00 Hrs [IST] Renalys Pharma, ...

Boehringer Ingelheim’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC: Ingelheim, Germany Monday, Oc ...

Keytruda plus Lenvima demonstrates durable 5-year survival benefit versus chemotherapy for patients with advanced endometrial carcinoma following one prior platinum-based regimen: ...

EMA committee recommends marketing approval for Novartis’ Scemblix to treat adults with newly diagnosed CML: Basel Monday, October 20, 2025, 11:00 Hrs [IST] Novartis announced t ...